The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
Dr. Dajun Yang, Ascentage Pharma CEO, joins 'Closing Bell Overtime' to talk today's IPO. Marilyn Manson won’t face sexual ...
Venture Global launched its initial public offering with a lofty goal: Raise up to $2.3 billion at a $110 billion valuation ...
The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...
After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...
1hon MSN
CLN Energy’s IPO, launched on January 23, has seen decent investor interest, being subscribed 2.81 times by day two. Retail ...
Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback